tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Jana built Cooper Companies stake, will push for deal, WSJ reports
The FlyJana built Cooper Companies stake, will push for deal, WSJ reports
5d ago
COO
BLCO
Bausch + Lomb price target raised to C$16 from C$15 at Citi
PremiumThe Fly
Bausch + Lomb price target raised to C$16 from C$15 at Citi
18d ago
BLCO
Bausch + Lomb initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Bausch + Lomb initiated with a Neutral at Goldman Sachs
24d ago
BLCO
Bausch + Lomb to Announce Q3 2025 Results and Host Investor Day
PremiumCompany Announcements
Bausch + Lomb to Announce Q3 2025 Results and Host Investor Day
26d ago
BLCO
Bausch + Lomb’s enVista Envy IOL Achieves Key Milestones in Clinical Trial
PremiumCompany Announcements
Bausch + Lomb’s enVista Envy IOL Achieves Key Milestones in Clinical Trial
1M ago
BLCO
Bausch + Lomb publishes enVista Envy trial results
PremiumThe FlyBausch + Lomb publishes enVista Envy trial results
1M ago
BLCO
Needham medtech & diagnostics analysts hold analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
2M ago
ALC
JNJ
Bausch + Lomb’s XIIDRA Shows Promising Results for Contact Lens Wearers
Premium
Company Announcements
Bausch + Lomb’s XIIDRA Shows Promising Results for Contact Lens Wearers
2M ago
BLCO
Bausch + Lomb publishes results from Xiidra 5% study
PremiumThe Fly
Bausch + Lomb publishes results from Xiidra 5% study
2M ago
BLCO
Bausch + Lomb Expands Specialty Vision Portfolio with ASANA Lens Launch
PremiumCompany Announcements
Bausch + Lomb Expands Specialty Vision Portfolio with ASANA Lens Launch
2M ago
BLCO
Bausch + Lomb Ends Agreement with Icahn Group
PremiumCompany Announcements
Bausch + Lomb Ends Agreement with Icahn Group
2M ago
8K
BLCO
Bausch + Lomb announces Brett Icahn, Gary Hu resign from board
PremiumThe Fly
Bausch + Lomb announces Brett Icahn, Gary Hu resign from board
2M ago
BLCO
Bausch + Lomb to Engage in Key September Investor Conferences
PremiumCompany AnnouncementsBausch + Lomb to Engage in Key September Investor Conferences
2M ago
BLCO
Bausch + Lomb price target raised to $13 from $11 at BofA
Premium
The Fly
Bausch + Lomb price target raised to $13 from $11 at BofA
3M ago
BHC
BLCO
Bausch + Lomb’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Bausch + Lomb’s Earnings Call: Growth Amid Challenges
3M ago
BLCO
Bausch + Lomb price target raised to $16 from $15 at H.C. Wainwright
PremiumThe Fly
Bausch + Lomb price target raised to $16 from $15 at H.C. Wainwright
3M ago
BLCO
Bausch + Lomb Reports Q2 2025 Financial Results
PremiumCompany Announcements
Bausch + Lomb Reports Q2 2025 Financial Results
3M ago
BLCO
Bausch + Lomb Reports Q2 2025 Revenue Growth, Raises Full-Year Guidance
PremiumCompany Announcements
Bausch + Lomb Reports Q2 2025 Revenue Growth, Raises Full-Year Guidance
3M ago
BLCO
Bausch + Lomb reports Q2 adjusted EPS 7c, consensus 8c
PremiumThe Fly
Bausch + Lomb reports Q2 adjusted EPS 7c, consensus 8c
3M ago
BLCO
Bausch + Lomb raises FY25 revenue view to $5.000B-$5.1050B from $5.000B-$5.100B
PremiumThe FlyBausch + Lomb raises FY25 revenue view to $5.000B-$5.1050B from $5.000B-$5.100B
3M ago
BLCO
Bausch + Lomb Confirms Efficacy of LUMIFY Preservative Free Eye Drops
Premium
Company Announcements
Bausch + Lomb Confirms Efficacy of LUMIFY Preservative Free Eye Drops
3M ago
BLCO
Bausch + Lomb publishes Lumify eye drops data in Ophthalmology and Therapy
Premium
The Fly
Bausch + Lomb publishes Lumify eye drops data in Ophthalmology and Therapy
3M ago
BLCO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >